Prestige Management Fights Back Following Biosimilar Rejection

CEO And COO Buy Up nearly 140,000 Shares To ‘Reinforce Trust’

 
• By Dean Rudge
  
Singapore (Prasit Rodphan/Alamy Stock Photo)
Prestige is appealing the EMA's verdict • Source: Shutterstock (Alamy Stock Photo)

More from Biosimilars

More from Products